(Q45979318)

18 December 2017

title

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. (English)

1 reference

18 December 2017

main subject

virology

0 references

anti-retroviral agent

0 references

author name string

Kitchen CM

1

1 reference

18 December 2017

Kitchen SG

2

1 reference

18 December 2017

Dubin JA

3

1 reference

18 December 2017

Gottlieb MS

4

1 reference

18 December 2017

language of work or name

English

0 references

publication date

11 July 2001

1 reference

18 December 2017

Clinical Infectious Diseases

published in

1 reference

18 December 2017

volume

33

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

466-472

1 reference

18 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

cites work

1 reference

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

21 January 2018

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

21 January 2018

HIV-protease inhibitors

1 reference

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

21 January 2018

1 reference

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

21 January 2018

1 reference

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

21 January 2018

1 reference

Determinants of virological response to antiretroviral therapy: implications for long-term strategies

21 January 2018

1 reference

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

21 January 2018

1 reference

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

21 January 2018

1 reference

CD4 cell counts at the third month of HAART may predict clinical failure.

21 January 2018

1 reference

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy

21 January 2018

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

21 January 2018

1 reference

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

21 January 2018

1 reference

Both Serum HIV Type 1 RNA Levels and CD4+ Lymphocyte Counts Predict Clinical Outcome in HIV Type 1-Infected Subjects with 200 to 500 CD4+ Cells per Cubic Millimeter

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/321900

1 reference

18 December 2017

1 reference

18 December 2017